Terconazole drug interactions: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
v__NOTOC__
__NOTOC__
{{Terconazole}}
{{Terconazole}}
{{CMG}}; {{AE}} {{AZ}}
{{CMG}}; {{AE}} {{AZ}}
Line 8: Line 8:


The therapeutic effect of these products is '''not affected''' by '''oral contraceptive''' usage.
The therapeutic effect of these products is '''not affected''' by '''oral contraceptive''' usage.


'''TERAZOL® 3 (terconazole) Vaginal Cream 0.8%'''
'''TERAZOL® 3 (terconazole) Vaginal Cream 0.8%'''

Latest revision as of 11:59, 9 January 2014

Terconazole
TERAZOL 7®,TERAZOL 3® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Drug Interactions

TERAZOL® 7 (terconazole) Vaginal Cream 0.4% and TERAZOL® 3 (terconazole) Vaginal Suppositories 80 mg

The therapeutic effect of these products is not affected by oral contraceptive usage.

TERAZOL® 3 (terconazole) Vaginal Cream 0.8%

The levels of estradiol (E2) and progesterone did not differ significantly when 0.8% terconazole vaginal cream was administered to healthy female volunteers established on a low dose oral contraceptive.[1]

References

  1. "TERAZOL 7 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) CREAM TERAZOL 3 (TERCONAZOLE) SUPPOSITORY [JANSSEN PHARMACEUTICALS, INC.]".

Adapted from the FDA Package Insert.